missing translation for 'onlineSavingsMsg'
Learn More

Trim22 Antibody (OTI1D11), DyLight 550, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-74608R

Product Code. 18105237

  • € 751.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Trim22 Monoclonal specifically detects Trim22 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Trim22
Monoclonal
DyLight 550
50mM Sodium Borate with 0.05% Sodium Azide
TRIM22
Recombinant protein fragment corresponding to amino acids 61-406 of human Trim22 (NP_006065) produced in E.coli.
0.1 mL
Primary
Human
IgG1
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence
OTI1D11
Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence
50 kDa-stimulated trans-acting factor, E3 ubiquitin-protein ligase TRIM22, EC 6.3.2, EC 6.3.2.-, GPSTAF50, RING finger protein 94, RNF94stimulated trans-acting factor (50 kDa), Staf-50, STAF50staf-50, tripartite binding motif 22, tripartite motif containing 22, tripartite motif protein TRIM22, tripartite motif-containing 22, Tripartite motif-containing protein 22
Mouse
Affinity Purified
Zinc Finger
10346.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.